Value Investing Research & Market Analysis

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Attovia Therapeutics, Inc.

News headline image
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ATTO
News headline image
Attovia Therapeutics to Participate in Upcoming Investor Conferences
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ATTO
News headline image
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ATTO
News headline image
Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ATTO
News headline image
Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
From Attovia Therapeutics, Inc.
Via GlobeNewswire
News headline image
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
From Attovia Therapeutics, Inc.
Via GlobeNewswire
News headline image
Attovia Therapeutics Announces First Participant Dosed in First-in-Human Phase 1 Study of ATTO-1310, its Novel Half-life Extended Anti-IL-31 ATTOBODY for the Treatment of Chronic Pruritus
From Attovia Therapeutics, Inc.
Via GlobeNewswire
News headline image
Attovia Therapeutics Appoints Chief Financial Officer
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers CNTB
News headline image
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ORIC
News headline image
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
From Attovia Therapeutics, Inc.
Via GlobeNewswire
News headline image
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
From Attovia Therapeutics, Inc.
Via GlobeNewswire
News headline image
Attovia Announces Second Tranche Closing of $60 Million Series A Financing and Highlights Progress Building a Best-in-Class Pipeline Leveraging the Attobody™ Platform
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.